1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. TAM Receptor

TAM Receptor

Receptor

Tyro3; Axl; Mer

TAM receptors, comprising of Tyro3, Axl and Mertk receptors, are receptor tyrosine kinases (RTKs) that are expressed by multiple immune cells including NK cells. The TAM family of receptors and their ligands Gas6 and Protein S (PROS1) are required for the optimal phagocytosis of apoptotic cells in the mature immune, nervous, and reproductive systems.

TAMs are three homologous type I receptor-tyrosine kinases that are activated by endogenous ligands, PROS1 and GAS6. These ligands can either activate TAMs as soluble factors, or, in turn, opsonize phosphatidylserine (PS) on apoptotic cells (ACs) and serve as bridging molecules between ACs and TAMs. Abnormal expression and activation of TAMs have been implicated in promoting proliferation and survival of cancer cells, as well as in suppressing anti-tumor immunity.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-145622
    Mecbotamab vedotin
    Inhibitor
    Mecbotamab vedotin (BA301) is an IgG1 antibody inhibitor of anti-(human tyrosine kinase receptor AXL) (human-Mus musculus monoclonal BA301 γ1-chain). Mecbotamab vedotin can be used to make immunoconjugates for Methods of Axl-expressing cancers research.
    Mecbotamab vedotin
  • HY-169517
    Protein kinase inhibitor 10
    Inhibitor
    Protein kinase inhibitor 10 is a protein kinase inhibitor with IC50 values of 28.9, 13.6, and 2.41 μM for TAM receptor, FAK, and KIT, respectively. Protein kinase inhibitor 10 can inhibit abnormal and excessive cell proliferation, showing promise for research in cancer therapy.
    Protein kinase inhibitor 10
  • HY-W400801
    Denfivontinib hydrochloride
    Inhibitor
    Denfivontinib (G-749) hydrochloride is an AXL inhibitor that has synergistic antitumor effects with the PD-1 inhibitor Pembrolizumab (HY-P9902). Denfivontinib can enhance the NOD-like receptor pathway, thereby promoting the formation of the NLRP3 inflammasome.
    Denfivontinib hydrochloride
  • HY-164382
    ER-851
    Inhibitor
    ER-851 is a selective AXL inhibitor with oral activity with IC50 of 100 nM. ER-851 has antitumor activity.
    ER-851
Cat. No. Product Name / Synonyms Species Source
Cat. No. Product Name / Synonyms Application Reactivity

Axl

Mer

Tyro3

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

TAM Receptor Inhibitors
Product NameAxlMerTyro3Purity    
Bemcentinib
Axl
  99.92%
Gilteritinib
Axl
  99.84%
Cabozantinib
Axl
  99.96%
2-D08
Axl
  99.17%
LDC1267
Axl
Mer
Tyro3
99.64%
UNC9426
Axl, IC50: 190 nM
MERTK, IC50: 580 nM
Tyro3, IC50: 2.1 nM
Dubermatinib
Axl
  99.84%
BMS 777607
Axl
 
Tyro3
99.33%
UNC2250
Axl
Mer
 99.92%
Zanzalintinib
Axl
Mer
 99.81%
Gilteritinib hemifumarate
Axl
  99.75%
UNC2541 
Mer
 99.71%
UNC569
Axl
Mer
Tyro3
99.87%
UNC5293
Axl
 
Tyro3
99.93%
Tamnorzatinib
Axl
Mer
Tyro3
98.07%
Batiraxcept
Axl
  99.91%
CEP-40783
Axl
  99.12%
UNC1062
Axl
 
Tyro3
99.48%
SGI-7079
Axl
  99.32%
Tilvestamab
Axl
  98.08%
Ningetinib
Axl
  99.82%
UNC2881
Axl
Mer
 99.79%
Enapotamab
Axl
  98.00%
NPS-1034
Axl
  ≥98.0%
RU-302
Axl
  98.72%
Cabozantinib-d6
Axl
  98.14%
UNC4203
Axl
 
Tyro3
99.80%
DS-1205b free base
Axl
Mer
 99.92%
PROTAC Axl Degrader 2
Axl
  98.01%
AXL-IN-13
Axl
  98.03%
Mipasetamab
Axl
  98.26%
Ningetinib Tosylate
Axl
  99.59%
Mecbotamab
Axl
  
TL4830031
Axl
  ≥98.0%
PF-07265807
Axl
Mer
Tyro3
AZ14145845
Axl
Mer
 
Cabozantinib hydrochloride
Axl
  
Axl-IN-6
Axl
  
Axl-IN-9
Axl
  
Axl-IN-11
Axl
  
PROTAC Axl Degrader 1
Axl
  
Axl-IN-4
Axl
  
Axl-IN-17
Axl, IC50: 3.23 nM
Mer
Tyro3
Axl-IN-10
Axl
  
Bemcentinib (GMP)
Axl
  
HIV-IN-7
Axl
  
Axl/Mer/CSF1R-IN-1
Axl
Mer
 
Axl-IN-12
Axl
  
AXL-IN-15
Axl
  
Axl-IN-7
Axl
  
Axl-IN-16
Axl
  
Axl-IN-8
Axl
  
Anticancer agent 109
Axl
  
Axl-IN-3
Axl
  
R916562
Axl
  
AXL-IN-14
Axl
  
Axl-IN-5
Axl